LEE PHARMA PVT LTD

LEE PHARMA PVT LTD Company Introduction

Lee Pharma Pvt Ltd is a prominent Indian pharmaceutical company established in 1997. It is recognized for its comprehensive capabilities in research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs), Pellets, and Finished Dosages. The company operates state-of-the-art manufacturing facilities that comply with international regulatory standards, ensuring the production of high-quality and cost-effective pharmaceutical products. Lee Pharma's product portfolio spans various therapeutic categories, including cardiovascular, anti-diabetic, anti-ulcer, anti-fungal, and anti-bacterial drugs. The company also provides contract manufacturing services and custom synthesis solutions to its global clientele.

Factory or Trader

Lee Pharma Pvt Ltd is a manufacturing company (a factory). It is directly involved in the production of Active Pharmaceutical Ingredients (APIs) and finished pharmaceutical formulations.

Company: LEE PHARMA PVT LTD

Products Manufactured or Sold:

1. Active Pharmaceutical Ingredients (APIs)

Lee Pharma specializes in a wide range of APIs across various therapeutic categories. Examples include:

Antidiabetic Agents: Metformin HCl, Gliclazide, Pioglitazone HCl

Antihypertensive Agents: Valsartan, Telmisartan, Olmesartan Medoxomil, Amlodipine Besylate

Lipid-Lowering Agents: Rosuvastatin Calcium, Atorvastatin Calcium

Antiviral Agents: Oseltamivir Phosphate, Favipiravir, Sofosbuvir, Remdesivir

Antifungal Agents: Posaconazole, Voriconazole, Fluconazole

Gastrointestinal Agents: Rabeprazole Sodium, Pantoprazole Sodium, Esomeprazole Magnesium

Central Nervous System (CNS) Agents: Pregabalin, Gabapentin, Dapoxetine HCl

Erectile Dysfunction Drugs: Tadalafil, Sildenafil Citrate

Other APIs: Rifaximin, Fenticonazole Nitrate

2. Pharmaceutical Intermediates

The company produces various chemical intermediates essential for the synthesis of their Active Pharmaceutical Ingredients.

3. Finished Formulations

Lee Pharma also manufactures and markets finished dosage forms such as tablets and capsules, incorporating some of their APIs, for both domestic and international markets.